The Alphabet Soup of Diabetes Care in the Hospital: SGLT2 Inhibitors and CGMs
This presentation will review how the list of new medications in diabetes is growing , how they work, and their safe use in the hospital setting.. In addition, use of diabetes technology--specifically continuous glucose monitors--is increasing, how hospitals are handling the large volume of patients wearing them is critical to safe care of patients with diabetes.
After listening to the presentation the learner will be able to:
1) Discuss the mechanism of action of sodium-glucose cotransporter-2 inhibitors and related safety considerations.
2) Describe clinical practice challenges and interventions to support patients using continuous glucose monitors in the hospital setting.
Gwen Kinkner, DNP, Rn, BC-ADM, CDCES, FADCES
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.
0.5 contact hours are approved for advanced pharmacotherapeutic contact hours
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
- 0.50 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 0.50 Pharmacotherapeutic
- 1.00 Attendance